Modafinil · Provigil

Small molecule

Approvedregulatory verdict

Evidence outlook

Approved: Narcolepsy

Regulatory approval supersedes design-level evidence grading; the trials behind approval are preserved below as the drug's evidence history.

How the evidence outlook works ↗

All registered studies

Every ClinicalTrials.gov study of this drug's own program. Studies backing a featured trial above are marked Featured; the rest aren't individually graded. Filter by which indication a study was run for, then browse by phase. Studies where this drug served as another program's comparator, or is merely referenced, are listed separately below.

Phase 3 (27)
Narcolepsy
NCT01067235 · Bioprojet
2009-10 – 2010-07 · Narcolepsy, Cataplexy, Excessive Daytime Sleepiness
What this study did
NCT00214968 · Cephalon
2005-01 – 2005-10 · Narcolepsy
What this study did
NCT00107848 · Cephalon
2004-10 – 2005-09 · Narcolepsy, Sleep Apnea, Obstructive
What this study did
Other / comorbidity
NCT07887412 · Kenneth Myers, MD
2026-12-01 – 2031-01-31 · Mitochondrial Disease
What this study did
NCT07231497 · University of Minnesota
2025-10-31 – 2030-04-30 · Cognition, Healthy Participants
What this study did
NCT07263022 · University of Minnesota
2026-07-17 – 2030-04-30 · Psychosis, Schizophrenia Disorder, Schizoaffective Disorder, Major Depressive Disorder With Psychotic Features, Bipolar Disorder With Psychotic Features, Psychosis NOS, Schizophreniform Disorder, Psychotic Disorder, Cognition
What this study did
NCT06354985 · University Health Network, Toronto
2025-09 – 2027-09 · Stroke, Fatigue, Modafinil, Exercise
What this study did
NCT04317001 · Stanford University
2018-12-01 – 2024-11-30 · Major Depressive Disorder
What this study did
NCT03185065 · Johns Hopkins University
2017-10-04 – 2019-11-21 · Fatigue in Multiple Sclerosis
What this study did
NCT03620253 · Unity Health Toronto
2018-10-15 – 2019-08-06 · Major Depressive Disorder, Cognitive Impairment
What this study did
NCT02028260 · Brigham and Women's Hospital
2014-01 – 2015-10 · Delirium, Respiratory Failure
What this study did
NCT01800097 · Herlev Hospital
2012-10 – 2015-03 · Stroke, Post Stroke Fatigue
What this study did
NCT01766323 · Dr. Rajendra Prasad Government Medical College
2012-09 – 2013-08 · Cancer, Pain Palliation, Excessive Sleepiness
What this study did
NCT00701532 · Assistance Publique - Hôpitaux de Paris
2009-04 – 2013-01 · Cocaine Addiction, Cocaine Dependence
What this study did
NCT01440621 · Indira Gandhi Medical College, Shimla
2010-08 – 2012-02 · Cancer Related Fatigue, Quality of Life
What this study did
NCT00917748 · Sanofi
2009-06 – 2011-03 · Prostatic Neoplasms, Breast Cancer
What this study did
NCT00418691 · M.D. Anderson Cancer Center
2004-02 – 2009-11 · Brain Tumor
What this study did
NCT00042848 · Gary Morrow
2002-08 – 2007-10 · Fatigue, Unspecified Adult Solid Tumor, Protocol Specific
What this study did
NCT01172145 · Brown University
2005-07 – 2007-09 · Apathy, Alzheimer's Disease
What this study did
NCT00267332 · Sidney Kimmel Comprehensive Cancer Center at Johns Hopkins
2006-01 – 2006-12 · Cancer, Pain
What this study did
NCT00228540 · Cephalon
2005-09 – 2006-09 · ADHD
What this study did
NCT00343811 · Cephalon
2006-06 – 2006-09 · Attention Deficit Hyperactivity Disorder
What this study did
NCT00214981 · Cephalon
2003-09 – 2006-09 · Attention Deficit/Hyperactivity Disorder, ADHD
What this study did
NCT00067496 · National Institute of Neurological Disorders and Stroke (NINDS)
2003-08 – 2006-08 · Postpoliomyelitis Syndrome
What this study did
NCT00236080 · Cephalon
2005-08 – 2005-12 · Chronic Shift Work Sleep Disorder
What this study did
Phase 2/3 (3)
Other / comorbidity
NCT07582458 · Radboud University Medical Center
2026-08-03 – 2027-06 · Inflammatory Bowel Disease (Crohn's Disease and Ulcerative Colitis), Chronic Fatigue
What this study did
NCT01726088 · Biomedical Research Foundation
2012-08 – 2014-05 · Posttraumatic Stress Disorder
What this study did
NCT00215176 · Duke University
2003-02 – 2005-04 · Atypical Depression
What this study did
Phase 2 (43)
Narcolepsy
NCT02821715 · Theranexus
2016-09 – 2019-02 · Narcolepsy
What this study did
Other / comorbidity
NCT07895134 · VA Office of Research and Development
2027-01-01 – 2031-12-31 · Major Depression
What this study did
NCT07295834 · Imperial College London
2026-02-01 – 2028-02-01 · Crohn Disease (CD), Ulcerative Colitis (UC), Fatigue
What this study did
NCT06592352 · Clinical Academic Center (2CA-Braga)
2024-08-27 – 2026-09 · Multiple Sclerosis, Cognitive Impairment
What this study did
NCT06404099 · Duke University
2024-08-12 – 2026-04-20 · Long COVID, Long COVID-19, Hypersomnia
What this study did
NCT06404086 · Duke University
2024-07-31 – 2025-12-31 · Long COVID, Long COVID-19, Hypersomnia, Sleep Disturbance
What this study did
NCT02896712 · The University of Texas Health Science Center, Houston
2016-11-18 – 2021-09-13 · Cocaine-Related Disorders
What this study did
NCT03083132 · University of Arkansas
2017-06-13 – 2019-11-12 · Parkinson Disease
What this study did
NCT03893032 · United States Army Aeromedical Research Laboratory
2019-07-17 – 2019-10 · Cognition
What this study did
NCT03424681 · The Mind Research Network
2017-12-11 – 2018-08-31 · Alcohol Use Disorder
What this study did
NCT02857244 · University of Chicago
2016-11 – 2017-11 · Parkinson's Disease
What this study did
NCT02376257 · Boston University Charles River Campus
2014-09-16 – 2017-05 · Major Depressive Disorder
What this study did
NCT01381718 · University of South Florida
2011-08 – 2016-08 · Brain and Central Nervous System Tumors, Cognitive/Functional Effects, Fatigue, Neurotoxicity, Psychosocial Effects of Cancer and Its Treatment
What this study did
NCT01085903 · University of Arkansas
2010-03 – 2015-08 · Spatial Neglect, Dysphagia
What this study did
NCT01137396 · Yale University
2010-04 – 2015-02 · Cocaine Dependence
What this study did
NCT00142818 · Kyle Kampman
2006-02 – 2013-08 · Alcohol-Related Disorders, Alcoholism, Cocaine-Related Disorders
What this study did
NCT01778010 · New York State Psychiatric Institute
2009-03 – 2013-06 · Cocaine Dependence
What this study did
NCT01354470 · California Pacific Medical Center Research Institute
2011-10 – 2013-02 · Methamphetamine Dependence
What this study did
NCT03914118 · The Cooper Health System
2008-01-01 – 2013-01-31 · Postoperative Cognitive Dysfunction
What this study did
NCT00368290 · Kyle Kampman
2006-09 – 2013-01 · Cocaine Dependence
What this study did
NCT01348607 · University of South Florida
2010-07 – 2012-12 · Central Nervous System Tumor, Pediatric, Fatigue, Specific Disorders of Sleep
What this study did
NCT00613015 · Medical University of South Carolina
2008-05 – 2012-07 · Cocaine Related Disorders
What this study did
NCT00838227 · Manhattan Psychiatric Center
2008-02 – 2012-06 · Schizophrenia
What this study did
NCT00218023 · The University of Texas Health Science Center, Houston
2006-03 – 2012-04 · Cocaine Abuse, Cocaine-Related Disorders
What this study did
NCT00218062 · The University of Texas Health Science Center, Houston
2006-03 – 2012-01 · Cocaine-Related Disorders
What this study did
NCT00630097 · California Pacific Medical Center Research Institute
2009-12 – 2011-06 · Substance Dependence, Amphetamine Dependence
What this study did
NCT00538655 · California Pacific Medical Center Research Institute
2008-01 – 2011-06 · Methamphetamine Addiction
What this study did
NCT00218387 · Medical University of South Carolina
2004-04 – 2010-07 · Cocaine Dependence
What this study did
NCT00520286 · National Institute on Drug Abuse (NIDA)
2007-12 – 2010-03 · Methamphetamine Dependence
What this study did
NCT00218036 · The University of Texas Health Science Center, Houston
2006-07 – 2010-02 · Cocaine Abuse, Opiate Dependence
What this study did
NCT00859573 · University of Arkansas
2009-04 – 2010-01 · Methamphetamine Dependence
What this study did
NCT00670813 · Technical University of Munich
2008-05 – 2009-11 · Depression
What this study did
NCT00620659 · Merck Sharp & Dohme LLC
2008-02 – 2009-02 · Sleep Apnea, Obstructive, Hypopnea Syndrome, Excessive Daytime Sleepiness
What this study did
NCT00469508 · University of California, Los Angeles
2007-04 – 2009-01 · Methamphetamine Dependence
What this study did
NCT00233090 · Icahn School of Medicine at Mount Sinai
2005-07 – 2008-12 · Fatigue
What this study did
NCT00569374 · University of Arkansas
2007-09 – 2008-09 · Methamphetamine Dependence
What this study did
NCT00129285 · University of Pennsylvania
2004-07 – 2008-04 · Cocaine-Related Disorders
What this study did
NCT00123383 · The University of New South Wales
2005-07 – 2007-09 · Cocaine Dependence
What this study did
NCT00123370 · The University of New South Wales
2006-07 – 2007-09 · Amphetamine Dependence
What this study did
NCT00344565 · Research Foundation for Mental Hygiene, Inc.
2005-11 – 2007-03 · Cocaine Dependence
What this study did
NCT00315276 · Cephalon
2006-05 – 2007-01 · Attention Deficit Hyperactivity Disorder, ADHD
What this study did
NCT00100100 · National Institute on Drug Abuse (NIDA)
2004-10 – 2006-12 · Cocaine-Related Disorders
What this study did
NCT00178373 · University of Rochester
2004-05 – 2006-03 · Cancer, Fatigue, Chemotherapy
What this study did
Phase 1/2 (5)
Other / comorbidity
NCT00262470 · Satish R. Raj
1997-04 – 2029-12 · Tachycardia, Chronic Orthostatic Intolerance
What this study did
NCT05333250 · Ottawa Hospital Research Institute
2026-03-16 – 2028-03 · Cancer-related Cognitive Difficulties, Cancer-related Problem/Condition, Fatigue
What this study did
NCT05351541 · Joshua Woolley, MD, PhD
2023-12-01 – 2026-08-07 · Chronic Low-back Pain
What this study did
NCT00838981 · Yale University
2008-05 – 2014-03 · Cocaine Dependence
What this study did
NCT00314639 · Laval University
2005-09 – 2008-06 · Schizophrenia and Schizophrenia Spectrum Psychosis
What this study did
Phase 1 (25)
Narcolepsy
NCT06619665 · Merck Sharp & Dohme LLC
2024-03-19 – 2024-07-16 · Healthy, Narcolepsy
What this study did
NCT06665230 · Merck Sharp & Dohme LLC
2023-09-20 – 2023-11-20 · Healthy, Narcolepsy
What this study did
Other / comorbidity
NCT05675098 · Kuwait University
2023-05-01 – 2027-02-01 · Neurodevelopmental Disorders, Cerebral Palsy
What this study did
NCT01988883 · Vanderbilt University Medical Center
2014-10 – 2026-12 · Postural Tachycardia Syndrome
What this study did
NCT07852130 · Abdulraheem Mohamed Gouda
2026-03-09 – 2026-09-12 · Healthy, Cognition, Sleep Deprivation
What this study did
NCT03864042 · Pfizer
2018-01-02 – 2023-05-29 · Advanced Solid Tumors, Metastatic Melanoma
What this study did
NCT03469089 · University of Eastern Finland
2018-03-12 – 2019-12-31 · Cognitive Symptom, Schizophrenia
What this study did
NCT03522506 · Takeda
2018-05-09 – 2018-11-07 · Healthy Volunteers
What this study did
NCT02538744 · Baylor College of Medicine
2015-08 – 2018-08-21 · Cocaine Dependence
What this study did
NCT00057707 · National Institute of Mental Health (NIMH)
2003-03-26 – 2017-06-16 · Schizophrenia, Schizoaffective Disorder
What this study did
NCT00223691 · Vanderbilt University
2002-03 – 2017-01 · Autonomic Failure, Orthostatic Hypotension
What this study did
NCT01951508 · University Hospital, Basel, Switzerland
2013-10 – 2014-12 · Healthy, Substance-related Disorder, Mood Disorder
What this study did
NCT01461174 · Qualissima
2011-11 – 2014-11 · Healthy
What this study did
NCT01903824 · Teva Branded Pharmaceutical Products R&D, Inc.
2013-08 – 2013-12 · Cognitive Impairment
What this study did
NCT01834547 · K. Lieb
2011-05 – 2013-04 · Cognitively Healthy Subjects Influenced by Psychoactive Drugs
What this study did
NCT01684306 · Università degli Studi 'G. d'Annunzio' Chieti e Pescara
2011-02 – 2012-01 · Fluid Inteligence, Modafinil, Healthy Young Subjects, Resting State Networks
What this study did
NCT00258479 · Catherine Martin, MD
2003-06 – 2011-12 · Tobacco Use Disorder
What this study did
NCT01601730 · Baylor College of Medicine
2010-08 – 2011-07 · Cocaine Dependence, Cocaine Abuse, Cocaine Addiction, Substance Abuse
What this study did
NCT01092780 · Merck Sharp & Dohme LLC
2010-05-26 – 2011-05-31 · Apnea, Sleep
What this study did
NCT00943176 · Mayo Clinic
2009-06 – 2011-04 · Fatigue, Primary Biliary Cirrhosis
What this study did
NCT00591019 · University of Arkansas
2006-08 – 2008-06 · Tinnitus
What this study did
NCT00265278 · National Institute on Drug Abuse (NIDA)
2005-03 – 2006-03 · Amphetamine-Related Disorders
What this study did
NCT00702637 · Craig Hospital
2002-10 – 2005-03 · Fatigue
What this study did
NCT00033046 · National Institute on Drug Abuse (NIDA)
2001-06 – 2002-04 · Cocaine-Related Disorders, Drug Administration Schedule, Infusions, Intravenous
What this study did
Phase 4 (22)
Other / comorbidity
NCT06041048 · University of California, Davis
2023-10-01 – 2026-12-19 · Attention - no Condition is Being Assessed - Healthy Adults
What this study did
NCT07830056 · United States Army Research Institute of Environmental Medicine
2025-02-18 – 2026-09-24 · Sleep Deprivation, Cold Exposure
What this study did
NCT03621761 · University of Michigan
2018-11-15 – 2021-11-30 · Multiple Sclerosis
What this study did
NCT03616717 · University of California, San Diego
2018-10-16 – 2021-09-30 · Healthy Adults
What this study did
NCT02494102 · Milton S. Hershey Medical Center
2016-02 – 2018-04-01 · Obstructive Sleep Apnea, Delayed Emergence From Anesthesia
What this study did
NCT01965925 · Icahn School of Medicine at Mount Sinai
2014-01 – 2017-11-09 · Bipolar Disorder
What this study did
NCT02155257 · Wake Forest University Health Sciences
2014-07 – 2017-10 · Osteoarthritis
What this study did
NCT01913327 · University of California, San Francisco
2013-04 – 2017-01 · Schizophrenia, Schizoaffective Disorder, Schizophreniform Disorder
What this study did
NCT02385656 · Seoul National University Bundang Hospital
2013-03 – 2016-02 · Fatigue
What this study did
NCT00423943 · University of California, Los Angeles
2005-09 – 2012-12 · Schizophrenia, Schizoaffective Disorder
What this study did
NCT00626210 · VA Palo Alto Health Care System
2008-02 – 2012-10 · Insomnia, Sleep Initiation and Maintenance Disorders, Alzheimer Disease
What this study did
NCT00711464 · University of California, Los Angeles
2008-05 – 2012-07 · Schizophrenia
What this study did
NCT00829322 · University of Oxford
2009-02 – 2012-05 · Carcinoma, Non-Small-Cell Lung
What this study did
NCT01365897 · Universidad de Valparaiso
2010-09 – 2011-01 · Attention, Memory, Short-Term, Executive Function
What this study did
NCT00118378 · New York State Psychiatric Institute
2004-12 – 2010-11 · HIV Infections, Fatigue
What this study did
NCT00751023 · Medical University of South Carolina
2009-02 – 2010-07 · Methamphetamine Dependence
What this study did
NCT00614926 · New York State Psychiatric Institute
2006-06 – 2008-07 · Fatigue
What this study did
NCT00573417 · North Suffolk Mental Health Association
2003-09 – 2007-11 · Schizophrenia
What this study did
NCT00124384 · University of Rochester
2005-01 – 2007-08 · Primary Insomnia
What this study did
NCT00086281 · Jazz Pharmaceuticals
2003-11 – 2005-11 · Obstructive Sleep Apnea Syndrome
What this study did
NCT00102284 · University Hospital Muenster
2004-03 – 2005-04 · Healthy
What this study did
NCT00208715 · Emory University
2003-02 – 2004-10 · Major Depression, Mental Health
What this study did
Early phase / not applicable (22)
Narcolepsy
NCT00916253 · University Hospital, Bordeaux
2010-03 – 2012-08 · Narcolepsy, Hypersomnia
What this study did
NCT00174174 · National Taiwan University Hospital
started 2003-09 · Narcolepsy, Cataplexy, Sleep Disorders, Hypersomnolence, Excessive Sleepiness
What this study did
Other / comorbidity
NCT07568574 · Enhanced Emirates Limited
2026-03-12 – 2033-03-01 · Safety and Impact of Medically Supervised Performance Enhancing Substance Usage in Healthy Elite Athletes
What this study did
NCT07128719 · Ain Shams University
2024-01-01 – 2025-06-01 · Obese Adolescents, Bariatric Surgery
What this study did
NCT03426202 · University of Electronic Science and Technology of China
2018-01-01 – 2020-07-01 · Healthy
What this study did
NCT02071615 · Charite University, Berlin, Germany
2013-08 – 2014-03 · Healthy
What this study did
NCT02051153 · Cambridge University Hospitals NHS Foundation Trust
2009-10 – 2011-09 · Cognitive Performance, Creativity, Motivation, Reward, Healthy Volunteers, Subjective Pleasure
What this study did
NCT00396734 · Hadassah Medical Organization
2007-04 – 2011-04 · Opioid-Related Disorders, Cocaine-Related Disorders
What this study did
NCT00052286 · Jonsson Comprehensive Cancer Center
2002-09 – 2010-08 · Brain and Central Nervous System Tumors, Cognitive/Functional Effects, Fatigue
What this study did
NCT00112515 · University of Virginia
started 2004-02 · Cognitive/Functional Effects, Depression, Fatigue, Unspecified Adult Solid Tumor, Protocol Specific
What this study did
NCT00582491 · Yale University
2006-08 – 2009-02 · Cocaine Dependence, Substance-induced Sleep Disorder, Substance-induced Cognitive Disorder
What this study did
NCT00489892 · Kessler Foundation
2003-08 – 2008-12 · Traumatic Brain Injury, Severe Traumatic Brain Injury
What this study did
NCT00546403 · Veterans Medical Research Foundation
2003-02 – 2008-02 · Schizophrenia
What this study did
NCT00393562 · US Department of Veterans Affairs
2006-03 – 2007-10 · Parkinson's Disease
What this study did
NCT00636896 · Neuropsychiatric Research Institute, Fargo, North Dakota
2006-07 – 2007-08 · Weight Gain
What this study did
NCT00895570 · Brigham and Women's Hospital
2005-01 – 2007-04 · Sleep Restriction, Impaired Glucose Metabolism
What this study did
NCT00297284 · Hospital for Special Surgery, New York
2006-02 – 2007-02 · Systemic Lupus Erythematosus
What this study did
NCT00220506 · Sheba Medical Center
2005-09 – 2006-12 · All Multiple Sclerosis Patients
What this study did
NCT00210301 · Institute for Clinical Research
started 2003-01 · Relapsing-Remitting Multiple Sclerosis
What this study did
NCT00142402 · Kessler Foundation
2003-06 – 2006-09 · Multiple Sclerosis
What this study did
NCT00305292 · University of California, San Francisco
2006-03 – 2006-08 · Alcohol
What this study did
Used as active comparator (8)

Other programs' studies in which this drug was the registered active-comparator arm: a marker of standard-of-care status, not evidence of this drug's own progression.

Phase 3 (2)
Narcolepsy
NCT01067222 · Bioprojet
2009-05 – 2010-12 · Narcolepsy, Excessive Daytime Sleepiness, Cataplexy, Sleep Disorders
What this study did
NCT00066170 · Jazz Pharmaceuticals
2003-04 – 2004-11 · Narcolepsy
What this study did
Phase 2 (2)
Narcolepsy
NCT03772314 · Emory University
2019-04-15 – 2023-05-04 · Idiopathic Hypersomnia, Narcolepsy Without Cataplexy
What this study did
NCT00424931 · Alza Corporation, DE, USA
2007-01 – 2007-12 · Narcolepsy
What this study did
Phase 1 (4)
Other / comorbidity
NCT02603861 · Eli Lilly and Company
2015-11 – 2016-03 · Healthy
What this study did
NCT03182413 · Theranexus
2015-09 – 2016-03 · Sleep Deprivation
What this study did
NCT00650000 · Mylan Pharmaceuticals Inc
2002-10 – 2002-10 · Healthy
What this study did
NCT00650286 · Mylan Pharmaceuticals Inc
2002-09 – 2002-10 · Healthy
What this study did
Appears in other studies (1)

Studies that reference this drug without giving it an intervention arm of its own: other formulations' programs, background therapy, or registry-search bleed.

Phase 1 (1)
Other / comorbidity
NCT02222441 · Pfizer
2014-10 – 2014-12 · Healthy
What this study did

Competitive landscape

This drug's own stage for Narcolepsy: Approved. Competitors below are sorted furthest-along first.

DrugStageModalityMechanismEvidence signalReported efficacygraded featured trials
Modafinil (Provigil): this drugApprovedSmall moleculeSympathomimetic-like Agentnot yet gradedNo reviewed efficacy summary in this indication
Calcium, Magnesium, Potassium And Sodium Oxybates (Xywav)ApprovedSmall moleculeGABA-B receptornot yet gradedNo reviewed efficacy summary in this indication
Oveporexton (Orzeyful)ApprovedSmall moleculeOrexin-2 receptor (agonist)not yet gradedNo reviewed efficacy summary in this indication
Pitolisant (Wakix)ApprovedSmall moleculeHistamine H3 receptor (antagonist / inverse agonist)Reliable signal
NCT02611687: To Evaluate the Efficacy of Pitolisant in Reducing Residual Excessive Daytime Sleepiness (EDS), Ullanlinna Narcolepsy Scale Score. (8 weeks): Pitolisant -6.29 score on a scale (Standard Error 1.14) | Placebo -2.6 score on a scale (Standard Error 1.35)
Sodium OxybateApprovedSmall moleculeGABA-B receptorPartial signalFeatured results are non-efficacy only in this race
Solriamfetol (Sunosi)ApprovedSmall moleculeDopamine/norepinephrine transporterPartial signal
NCT02348632: Change in Epworth Sleepiness Scale score from the start to the end of the 2-week randomized-withdrawal period (positive = worse): +1.6 with continued solriamfetol (n=139) vs +5.3 after switch to placebo (n=141); difference -3.7 points (95% CI -4.8 to -2.7), significant after multiplicity adjustment (SUNOSI label Table 8; CT.gov posted results).
NCT02348593: Change from baseline to week 12 vs placebo: MWT +12.3 (300 mg) and +9.8 (150 mg) vs +2.1 minutes; ESS -6.4 and -5.4 vs -1.6 points (all p<0.0001). The 75 mg dose (MWT +4.74, ESS -3.8) was not statistically significant on either coprimary (Thorpy et al., Ann Neurol 2019; SUNOSI label).
AlixorextonPhase 3Small moleculeOrexin-2 receptor (agonist)not yet gradedNo reviewed efficacy summary in this indication
ReboxetinePhase 3Small moleculenorepinephrine transporterPartial signal
NCT05113745: Primary endpoint, change in frequency of cataplexy attacks in the randomized withdrawal phase: statistically significant improvement vs placebo (Axsome, 2024-11-26).
CleminorextonPhase 2/3Small molecule—not yet gradedNo reviewed efficacy summary in this indication
TAK-360Phase 2/3Small moleculeOrexin-2 receptor (agonist)not yet gradedNo reviewed efficacy summary in this indication
Pitolisant GR
—(overall)
Small moleculeHistamine H3 receptor (antagonist / inverse agonist)not yet gradedNo reviewed efficacy summary in this indication

Upcoming events

(12 total)

Estimated primary-completion dates from ClinicalTrials.gov. These are registry estimates, never confirmed readout dates; they can move as trials progress.

Follow Provigil (Modafinil) to get an email as a readout nears, when a date moves, or when a study changes status. Needs a free account.

Add these readouts to your calendar: Apple or Outlook · Google Calendar · .ics link. The calendar updates when a registry date moves.

2026 (2)
December 2026 (2)
Phase 1Postural Tachycardia SyndromeActive not recruiting
Est. primary completion 2026-12 · NCT01988883 · CT.gov ↗
What to watch
Phase 4Attention - no Condition is Being Assessed - Healthy AdultsRecruiting
Est. primary completion 2026-12-19 · NCT06041048 · CT.gov ↗
What to watch
2027 (4)
February 2027 (1)
Phase 2/3Inflammatory Bowel Disease (Crohn&#39;s Disease and Ulcerative Colitis), Chronic FatigueRecruiting
Est. primary completion 2027-02-01 · NCT07582458 · CT.gov ↗
What to watch
September 2027 (1)
Phase 3Stroke, Fatigue, Modafinil, ExerciseNot yet recruiting
Est. primary completion 2027-09 · NCT06354985 · CT.gov ↗
What to watch
October 2027 (1)
Phase 1/2Cancer-related Cognitive Difficulties, Cancer-related Problem/Condition, FatigueRecruiting
Est. primary completion 2027-10 · NCT05333250 · CT.gov ↗
What to watch
December 2027 (1)
Phase 2Crohn Disease (CD), Ulcerative Colitis (UC), FatigueNot yet recruiting
Est. primary completion 2027-12-01 · NCT07295834 · CT.gov ↗
What to watch
2028 (1)
May 2028 (1)
Early phase / not applicableSafety and Impact of Medically Supervised Performance Enhancing Substance Usage in Healthy Elite AthletesEnrolling by invitation
Est. primary completion 2028-05-01 · NCT07568574 · CT.gov ↗
What to watch
2029 (2)
January 2029 (1)
Phase 3Mitochondrial DiseaseNot yet recruiting
Est. primary completion 2029-01-31 · NCT07887412 · CT.gov ↗
What to watch
December 2029 (1)
Phase 1/2Tachycardia, Chronic Orthostatic IntoleranceActive not recruiting
Est. primary completion 2029-12 · NCT00262470 · CT.gov ↗
What to watch
2030 (2)
April 2030 (2)
Phase 3Cognition, Healthy ParticipantsRecruiting
Est. primary completion 2030-04-30 · NCT07231497 · CT.gov ↗
What to watch
Phase 3Psychosis, Schizophrenia Disorder, Schizoaffective Disorder, Major Depressive Disorder With Psychotic Features …Recruiting
Est. primary completion 2030-04-30 · NCT07263022 · CT.gov ↗
What to watch
2031 (1)
December 2031 (1)
Phase 2Major DepressionNot yet recruiting
Est. primary completion 2031-12-31 · NCT07895134 · CT.gov ↗
What to watch

See the full readout calendar ↗